Standout Papers

DT‐01‐04: The efficacy of RVT‐101, a 5‐ht6 receptor antagonist, as an adjunct to donepezil in adults... 2015 2026 2018 2022 578
  1. DT‐01‐04: The efficacy of RVT‐101, a 5‐ht6 receptor antagonist, as an adjunct to donepezil in adults with mild‐to‐moderate Alzheimer's disease: Completer analysis of a phase 2b study (2015)
    Ilise Lombardo, Geetha Ramaswamy et al. Alzheimer s & Dementia

Immediate Impact

2 by Nobel laureates 32 from Science/Nature 62 standout
Sub-graph 1 of 20

Citing Papers

Atopic dermatitis
2025 Standout
Glymphatic failure as a final common pathway to dementia
2020 StandoutScience
2 intermediate papers

Works of Stephen C. Piscitelli being referenced

Tapinarof cream 1% once daily: Significant efficacy in the treatment of moderate to severe atopic dermatitis in adults and children down to 2 years of age in the pivotal phase 3 ADORING trials
2024
DT‐01‐04: The efficacy of RVT‐101, a 5‐ht6 receptor antagonist, as an adjunct to donepezil in adults with mild‐to‐moderate Alzheimer's disease: Completer analysis of a phase 2b study
2015 Standout
and 1 more

Author Peers

Author Last Decade Papers Cites
Stephen C. Piscitelli 4281 2061 2044 165 7.6k
David W. Haas 4487 1984 3097 210 8.4k
Giovanni Di Perri 3744 2151 1595 405 7.4k
George Gee Jackson 3161 2839 1951 142 7.4k
Laurent A. Décosterd 3743 1500 2176 265 9.8k
Saye Khoo 5722 2060 2844 325 8.6k
Edward P. Acosta 5576 1542 3984 207 7.9k
Angela D. M. Kashuba 6519 2798 4768 312 10.9k
Courtney V. Fletcher 5317 2082 4089 226 8.2k
Tomáš Cihlář 7589 2708 2564 142 11.0k
Francesca Aweeka 2614 846 1603 143 5.2k

All Works

Loading papers...

Rankless by CCL
2026